Characterization of K(ATP) channels in intact mammalian skeletal muscle fibres

British Journal of Pharmacology

Volumn 123, Issue 6, 1998, Pages 1103-1110

  Barrett Jolley, Richard ^a   McPherson, Grant A ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

Author keywords

5 hydroxydecanoic acid; ATP sensitive; Diazoxide; Glibenclamide; K(ATP) potassium channel; Levcromakalim cromakalim; Skeletal muscle; Tolbutamide

Indexed keywords

GLIBENCLAMIDE; GLIPIZIDE; LEMAKALIM; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; TOLBUTAMIDE;

ANIMAL CELL; ARTICLE; DRUG POTENCY; MEMBRANE CURRENT; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGRESSION ANALYSIS; SKELETAL MUSCLE;

ANIMALS; CROMAKALIM; GLYBURIDE; MUSCLE FIBERS; MUSCLE, SKELETAL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS;

EID: 0031934730     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701727     Document Type: Article

References (41)

1. + channels in mammalian skeletal muscle. Eur. J. Pharmacol., 236, 419-426.
2. + channels. Cell. Signalling, 2, 197-294.
3. AUCHAMPACH, J.A., GROVER, G.J. & GROSS, J.A. (1992). Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxyde-canoate. Cardiovasc. Res., 26, 1054-1062.
4. BARRETT-JOLLEY, R. & DAVIES, N.W. (1997). Kinetic analysis of the inhibitory effect of glibenclamide on K(ATP) channels of mammalian skeletal muscle. J. Memb. Biol., 155, 257-262.
5. BEKOFF, A. & BETZ, W.J. (1977). Physiological properties of dissociated muscle fibres obtained from innervated and denervated adult rat muscle. J. Physiol., 271, 25-40.
6. BLACK, J.W. & SHANKLEY, N.P. (1985). The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis. Br. J. Pharmacol., 86, 571-579.
7. BUCKINGHAM, R.E., HAMILTON, T.C., HOWLETT, D.R., MOOTOO, S. & WILSON, C. (1989). Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br. J. Pharmacol., 97, 57-64.
8. CHALLINOR, J.L. & McPHERSON, G.A. (1993). Evidence that imidazol(id)ine- and sulphonylurea based antagonists of cromakalim act at different sites in the rat thoracic aorta. Clin. Exp. Pharmacol. Physiol., 20, 467-475.
9. 3H]-glibenclamide binding to membranes from rat cerebral cortex. J. Pharmacol. Exp. Ther., 273, 778-786.
10. ATP channels. Diabetes, 15, 1439-1445.
11. DAVIES, N.W., STANDEN, N.B. & STANFIELD, P.R. (1991). ATP-dependent potassium channels of muscle cells: their properties, regulation, and possible functions. J. Bioenerg. Biomembr., 23, 509 535.
12. DAWSON, M.J., GADIAN, D.G. & WILKIE, D.R. (1978). Muscular fatigue investigated by phosphorous nuclear magnetic resonance. Nature, 274, 861-866.
13. DICKINSON, K.E.J., BRYSON, C.C., COHEN, R.B., ROGERS, L., GREEN, D.W. & ATWAL, K.S. (1997). Nucleotide regulation and characteristics of potassium channel opener binding to skeletal muscle membranes. Mol. Pharmacol., 52, 473-481.
14. DUNNE, M.J., ASPINALL, R.J. & PETERSEN, O.H. (1990). The effects of cromakalim on ATP-sensitive potassium channels in insulin-secreting cells. Br. J. Pharmacol., 99, 169-175.
15. ESCANDE, D., THURINGER, D., LEGUERIN, S. & CAVERO, I. (1988). The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes. Biochem. Biophys. Res. Commun., 154, 620-625.
16. FAIVRE, J.F. & FINDLAY, I. (1989). Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle. Biochem. Biophys. Acta. 984, 1-5.
17. + channels in cardiac muscle by the sulphonylurea drug glibenclamide. J. Pharmacol. Exp. Ther., 261, 540-545.
18. 3H] glyburide, to neuronal and muscle preparations. J. Pharmacol. Exp. Ther., 257, 1162-1171.
19. GRIBBLE, F.M., TUCKER, S.J. & ASHCROFT, F.M. (1997). The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation. J. Physiol., 504, 35-45.
20. HUSSAIN, M., WAREHAM, A.C. & HEAD, S.I. (1994). Mechanism of action of a K+ channel activator BRL-38227 on ATP-sensitive K+ channels in mouse skeletal-muscle fibers. J. Physiol., 478, 523-532.
21. ATp: An inward rectifier subunit plus the sulphonylurea receptor. Science, 270, 1166-1170.
22. INAGAKI, N., GONOI, T., CLEMENT IV, J.P., WANG, C.-Z., AGUILAR-BRYAN, L., BRYAN, J. & SEINO, S. (1996). A family of sulphonylurea receptors determines the pharmacological properties of ATP-sensitive K channels. Neuron, 16, 1011-1017.
23. + channel. J. Biol. Chem., 271, 24321-24324.
24. KRAUSE, E., ENGLERT, H. & GÖGELEIN, H. (1995). Adenosine triphosphate dependent K currents activated by metabolic inhibition differ from those elicited by the channel opener rimakalim. Pflügers Archiv., 429, 625.
25. LÖFFLER, C. & QUAST, U. (1997). Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta. Br. J. Pharmacol., 120, 476-480.
26. McKILLEN, H.-C. (1993). A sarcolemmal vesicle preparation from rat isolated skeletal muscle suitable for patch-clamp experiments. J. Physiol., 467, 242P.
27. MCKILLEN, H.-C., DAVIES, N.W., STANFIELD, P.R. & STANDEN, N.B. (1994). The effect of intracellular anions on ATP-dependent potassium channels of rat skeletal muscle. J. Physiol., 479, 341-351.
28. NOTSU, T., OHHASHI, K., TANAKA, I., ISHIKAWA, H., NIHO, T., FUKUTAKE, K. & MIZOTA, M. (1992a). 5-Hydroxydecanoate inhibits ATP-sensitive K+ channel currents in guinea-pig single ventricular myocytes. Eur. J. Pharmacol., 220, 35-41.
29. NOTSU, T., TANAKA, I., TAKANO, M. & NOMA, A. (1992b). Blockade of the ATP-sensitive K+ channel by 5-hydroxydecanoate in guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther., 260, 702-708.
30. PANTEN, U., BURGFIELD, J., GOERKE, F., RENNICKE, M., SCHWANSTECHER, M., WALLASCH, A., ZÜNKLER, B.J. & LENZEN, S. (1989). Control of insulin secretion by sulphonylureas, meglitnide and diazoxide in relation to their binding to the sulphonylurea receptor in pancreatic islets. Biochem. Pharmacol., 38, 1217-1229.
31. QUAST, U. & COOK, N.S. (1988). In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. J. Pharmacol. Exp. Ther., 250, 261-271.
32. + currents in smooth muscle cells from rabbit mesenteric arteries. Am. J. Physiol., 269, C1112-C1118.
33. QUAYLE, J.M., NELSON, M.T. & STANDEN, N.B. (1997). ATP sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol. Rev., 77, 1165-1232.
34. RUSSELL, S.N., SMIRNOV, S.V. & AARONSON, P.I. (1992). Effects of BRL38277 on potassium currents in smooth muscle cells isolated from rabbit portal vein and human mesenteric artery. Br. J. Pharmacol., 105, 549-556.
35. + channel in insulin secreting cells. Biochem. Biophys. Res. Commun., 146, 21-25.
36. ATP channel antagonist, 5HD, blocks ischaemic preconditioning in the rat heart. J. Mol. Cell. Cardio., 29, 1055-1060.
37. TUCKER, S.J., GRIBBLE, F.M., ZHAO, C., TRAPP, S. & ASHCROFT, F.M. (1997). Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature, 387, 179-183.
38. WEIK, R. & NEUMCKE, B. (1990). Effects of potassium channel openers on single potassium channels in mouse skeletal-muscle. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 258-263.
39. + channel activators in vitro. J. Auton. Pharmacol., 9, 71-78.
40. WOLL, K.H., LONNENDONKER, U. & NEUMCKE, B. (1989). ATP-sensitive potassium channels in adult-mouse skeletal-muscle -different modes of blockage by internal cations, ATP and tolbutamide. Pflügers Archiv., 414, 622-628.
41. + channel. J. Physiol. 499(3), 715-720.